KocasCYildizAAbaciO. Platelet-to-lymphocyte ratio predicts contrast-ınduced nephropathy in patients with non-ST-segment elevation acute coronary syndrome. Angiology. doi:10.1177/0003319715578057.
2.
BarışNÖzpelitEDoğanNB. The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients. Anadolu Kardiyol Derg. 2013;13(3):245–250.
3.
OzcanEEGuneriSAkdenizB. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J. 2007;154(3):539–544.
4.
KatsikiNAthyrosVGKaragiannisAMikhailidisDP. Contrast-induced nephropathy: an “all or none” phenomenon?Angiology. 2015;66(6):508–513.
5.
AbaciOHarmankayaOKocasB. Long-term follow-up of patients at high risk for nephropathy after contrast exposure. Angiology. 2015;66(6):514–518.
